S-BIOTEK ApS: Financial statements 2022
CVR: 29420297
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
S-BIOTEK ApS (CVR 29420297) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -6,250 and a net result of DKK 395,829 compared with DKK -25,379 the year before. Equity in the 2022 report amounted to DKK -5,000.
- Gross Profit
- DKK -6,250
- Profit/Loss
- DKK 395,829
- Equity
- DKK -5,000
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -6 t. | 396 t. | -5 t. | 0 |
| 2021 | - | -6 t. | -25 t. | -424 t. | - |
| 2020 | - | -6 t. | -22 t. | -399 t. | - |
| 2019 | - | -6 t. | -21 t. | -377 t. | - |
| 2018 | - | -5 t. | -14 t. | -12 t. | - |
Official annual report
Keep an eye on S-BIOTEK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of July 15, 2022, René Brinch Jørgensen is registered as director of S-BIOTEK ApS.
As of July 15, 2022, Jørgen Schönherr has stepped down as director of S-BIOTEK ApS.
As of July 15, 2022, Brian Malm has stepped down as director of S-BIOTEK ApS.
About S-BIOTEK ApS
S-BIOTEK ApS was a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2006. The company has been dissolved on 11 January 2024. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DS 50 ApS. According to the 2023 annual report, the company had an average of 0 employees. In 2023, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK 395,829 the year before. Equity in the 2023 report amounted to DKK -8,750.